Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 50 Results

Intervention Indication Therapeutic Area Year Actions
Rezafungin for previously untreated invasive candidiasis Rezafungin (CD101) Invasive candidasis Haematology , Infectious Disease 2022 View  |  Download
Ravulizumab for treating thrombotic microangiopathies following haematopoietic stem cell transplantation in children Ravulizumab (ALXN1210; Ultomiris) Thrombotic microangiopathies Haematology 2023 View  |  Download
Ravulizumab for paroxysmal nocturnal haemoglobinuria in paediatrics Ravulizumab (ALXN1210; Ultomiris) Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2021 View  |  Download
Ravulizumab for atypical haemolytic uraemic syndrome in adults and children – first line Ravulizumab (ALXN1210; Ultomiris) Atypical haemolytic uraemic syndrome (aHUS) Haematology , Nephrology 2018 View  |  Download
Ravulizumab (subcutaneous formulation) for treating paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome Ravulizumab (ALXN1210; Ultomiris) Atypical haemolytic uraemic syndrome (aHUS) , Paroxysmal nocturnal haemoglobinuria (PNH) Haematology , Nephrology 2022 View  |  Download
Pegcetacoplan (APL-2) for paroxysmal nocturnal haemoglobinuria Pegcetacoplan (APL-2) Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2019 View  |  Download
Momelotinib for the treatment of symptomatic and anaemic myelofibrosis Momelotinib Anaemic myelofibrosis Haematological Cancer and Lymphomas , Haematology 2022 View  |  Download
Mim8 for prophylaxis of haemophilia A NNC0365-3769 Haemophilia A Haematology 2023 View  |  Download
Marstacimab for the treatment of haemophilia A and haemophilia B Marstacimab (PF-06741086) Haemophilia A , Haemophilia B Haematology 2023 View  |  Download
Luspatercept for the treatment of adults with non-transfusion dependent beta-thalassaemia Luspatercept (ACE-536; Reblozyl) Beta thalassemia Genetic Disorders , Haematology 2020 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications